IVW-1001 not checked

IVIEW Therapeutics Inc.

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Dry Eye Disease (2 trials), Dry Eye
Main trialPhase 2
“Double-masked two period controlled trial of three eyelid wipe dosing techniques”In the company’s words, NCT07140380 on ClinicalTrials.gov

Other drugs for Dry Eye Disease

All 44 drugs for Dry Eye Disease

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 2Completed 8 Oct 2025 Phase 2b Controlled Study
Phase 2Completed 3 Nov 2025 Phase 2b Controlled Study of Dosing Techniques - Part B
Phase 1/2Completed 15 Oct 2024 IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow IVW-1001

Following is part of Solo: you see every change to IVW-1001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in